Xiaoping Qing

1.4k citations

23 papers · 1.1k indexed · h-index 15

Impact in

Nephrology top 5%
- Renal Diseases and Glomerulopathies
Rheumatology top 2%
- Systemic Lupus Erythematosus Research

Papers in

Immunology 13
- T-cell and B-cell Immunology 6
- Immunotherapy and Immune Responses 3
Nephrology 4
- Renal Diseases and Glomerulopathies 3

Co-authors: Chaim Putterman Jane E. Salmon Juan Javier Lichauco Bisram Deocharan Patricia Redecha Milena Pitashny Tak W. Mak Carl Blobel
Journals: Journal of Clinical Oncology (4 papers)The Journal of Immunology (2 papers)Journal of Clinical Investigation (2 papers)European Journal of Immunology (2 papers)Frontiers in Oncology (1 paper)
Partner nations: United States Canada Australia

In The Last Decade

Xiaoping Qing

22 papers receiving 1.1k citations

Peers

Countries citing papers authored by Xiaoping Qing

Since Specialization

Citations

This map shows the geographic impact of Xiaoping Qing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Qing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Qing more than expected).

Fields of papers citing papers by Xiaoping Qing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoping Qing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Qing. The network helps show where Xiaoping Qing may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xiaoping Qing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaoping Qing Line = papers co-authored together Xiaoping Qing links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	HB-200 arenavirus-based immunotherapy plus pembrolizumab as first-line treatment of patients with recurrent/metastatic HPV16-positive head and neck cancer: Updated results. Journal of Clinical Oncology ·Alan L. Ho, Lisle Nabell, Prakash Neupane, Marshall R. Posner, Emrullah Yilmaz, Jiaxin Niu, Abdul Rafeh Naqash, Alexander T. Pearson, Stuart J. Wong, Jorge J. Nieva, Douglas Laux, Deborah J. Wong, Zujun Li, Ari J. Rosenberg, Winston Wong, Xiaoping Qing, Wendy Vanesa Ricardo Benitez, Henning Lauterbach, Ilian Tchakov, David G. Pfister	2024	5
2	Recommended phase 2 dose (RP2D) of HB-200 arenavirus-based cancer immunotherapies in patients with HPV16+ cancers. Journal of Clinical Oncology ·Siqing Fu, Lisle M. Nabell, Alexander T. Pearson, Rom S. Leidner, Douglas Adkins, Marshall R. Posner, Jorge J. Nieva, Debra L. Richardson, L. Hauschild, Sanjay Goel, Stuart J. Wong, Alan L. Ho, Ari Rosenberg, Matthew H. Taylor, Tarasov A.V. Tarasov, Wendy Vanesa Ricardo Benitez, Xiaoping Qing, みのり星川, Katia Schlienger, David G. Pfister	2022	3
3	Development and Characterization of a Novel Non-Lytic Cancer Immunotherapy Using a Recombinant Arenavirus Vector Platform Frontiers in Oncology ·Henning Lauterbach, Sarah Schmidt, みのり星川, Xiaoping Qing, Wendy Vanesa Ricardo Benitez, P. Infelise, Katia Schlienger, Ursula Berka, Yang XianJin, R. Rodriguez, Karel Složil, P. Khulová, Daniel D. Pinschewer, Igor Matushansky, Klaus K. Orlinger	2021	15
4	First report of the safety/tolerability and preliminary antitumor activity of HB-201 and HB-202, an arenavirus-based cancer immunotherapy, in patients with HPV16+ cancers. Journal of Clinical Oncology ·Alan L. Ho, Marshall R. Posner, Jiaxin Niu, Siqing Fu, Rom S. Leidner, Alexander T. Pearson, Ki Y. Chung, Debra L. Richardson, Ding Wang, L. Hauschild, Jorge J. Nieva, Ari J. Rosenberg, Bharat Burman, Wendy Vanesa Ricardo Benitez, Xiaoping Qing, P. Infelise, みのり星川, Katia Schlienger, Igor Matushansky, David G. Pfister	2021	5
5	Structure–Activity Relationships of Noncovalent Immunoproteasome β5i-Selective Dipeptides Journal of Medicinal Chemistry ·Wenhu Zhan, Pradeep K. Singh, Yi Ban, Xiaoping Qing, Marie Dominique Ah Kioon, Hao Fan, Quanju Zhao, Rong Wang, George Sukenick, Jane E. Salmon, J. David Warren, Xiaojing Ma, Franck J. Barrat, Carl Nathan, Gang Lin	2020	11
6	Live-attenuated lymphocytic choriomeningitis virus-based vaccines for active immunotherapy of HPV16-positive cancer OncoImmunology ·Sarah Schmidt, Weldy V. Bonilla, Andrea Reiter, P. Khulová, A Nixon, A. Szłapa, Ursula Berka, Ahmed El‐Gazzar, Moisés Natanael de los Santos Rodríguez, William A. Altemier, Yang XianJin, Mohamed Habbeddine, ALFRED KING, Xiaoping Qing, Henning Lauterbach, Igor Matushansky, Daniel D. Pinschewer, Klaus K. Orlinger	2020	13
7	iRhom2 promotes lupus nephritis through TNF-α and EGFR signaling Journal of Clinical Investigation ·Xiaoping Qing, Yurii Chinenov, Patricia Redecha, Michael P. Madaio, Joris J. T. H. Roelofs, 陈慧超, Priya D. Issuree, Laura T. Donlin, Hal Foster, Tak W. Mak, Carl Blobel, Jane E. Salmon	2018	67
8	A protective Langerhans cell–keratinocyte axis that is dysfunctional in photosensitivity Science Translational Medicine ·William Shipman, Susan Chyou, Anusha Ramanathan, Peter Izmirly, Sneh Sharma, Tania Pannellini, Dragos Dasoveanu, Xiaoping Qing, Cynthia M. Magro, Richard D. Granstein, Michelle A. Lowes, Eric G. Pamer, Daniel H. Kaplan, Jane E. Salmon, Babak J. Mehrara, James W. Young, Robert M. Clancy, Carl Blobel, Theresa T. Lu	2018	54
9	iRhom2 regulates CSF1R cell surface expression and non‐steady state myelopoiesis in mice European Journal of Immunology ·Xiaoping Qing, Lindsay D. Rogers, Arthur Mortha, Yonit Lavin, Patricia Redecha, Priya D. Issuree, Thorsten Maretzky, Miriam Mérad, David R. McIlwain, Tak W. Mak, Christopher M. Overall, Carl Blobel, Jane E. Salmon	2016	16
10	iRHOM2 is a critical pathogenic mediator of inflammatory arthritis Journal of Clinical Investigation ·Priya D. Issuree, Thorsten Maretzky, David R. McIlwain, Sébastien Monette, Xiaoping Qing, Philipp A. Lang, Steven Swendeman, Kyung-Hyun Park-Min, Nikolaus B. Binder, George D. Kalliolias, Anna Yarilina, Keisuke Horiuchi, Lionel B. Ivashkiv, Tak W. Mak, Jane E. Salmon, Carl Blobel	2013	128
11	Cholinergic Receptors Modulate Immune Complex–Induced Inflammation In Vitro and In Vivo The Journal of Immunology ·Milena Vukelic, Xiaoping Qing, Patricia Redecha, Gloria C. Koo, Jane E. Salmon	2013	22
12	Complement regulates conventional DC‐mediated NK‐cell activation by inducing TGF‐β1 in Gr‐1⁺ myeloid cells European Journal of Immunology ·Xiaoping Qing, Gloria C. Koo, Jane E. Salmon	2012	14
13	Engraftment of peripheral blood mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors into BALB‐RAG‐2^−/−IL‐2Rγ^−/− mice: A promising model for studying human disease Arthritis & Rheumatism ·Danieli Andrade, Patricia Redecha, Milena Vukelic, Xiaoping Qing, Giorgio Perino, Jane E. Salmon, Gloria C. Koo	2011	51
14	Neutrophil gelatinase–associated lipocalin is instrumental in the pathogenesis of antibody‐mediated nephritis in mice Arthritis & Rheumatism ·Rahul D. Pawar, Milena Pitashny, E.L.G. Mattioli, Maria S. Perez-Hern'ndez, Ren Da-guang, Béatrice Goilav, Sean R. Campbell, Yumin Xia, Xiaoping Qing, David B. Thomas, Leal Herlitz, Thorsten Berger, Tak W. Mak, Chaim Putterman	2011	42
15	Targeted inhibition of complement activation prevents features of preeclampsia in mice Kidney International ·Xiaoping Qing, Patricia Redecha, Melissa A. Burmeister, Stephen Tomlinson, Vivette D. D’Agati, Robin L. Davisson, Jane E. Salmon	2010	71
16	Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: Involvement of HMGB1 in anti-DNA antibody-induced renal injury Immunology Letters ·Xiaoping Qing, Milena Pitashny, David B. Thomas, Franck J. Barrat, P. Mark Hogarth, Chaim Putterman	2008	66
17	Urinary lipocalin‐2 is associated with renal disease activity in human lupus nephritis Arthritis & Rheumatism ·Milena Pitashny, Noa Schwartz, Xiaoping Qing, Diana García-Monroy, Cynthia Aranow, Meggan Mackay, Chaim Putterman	2007	108
18	Nephritogenic Anti‐DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells Arthritis & Rheumatism ·Xiaoping Qing, Jiří Zavadil, Michelle B. Crosby, P. Mark Hogarth, Bevra H. Hahn, Chandra Mohan, Gary S. Gilkeson, Erwin P. Böttinger, Chaim Putterman	2006	68
19	Gene expression profiling in the study of the pathogenesis of systemic lupus erythematosus Autoimmunity Reviews ·Xiaoping Qing, Chaim Putterman	2004	39
20	α-Actinin Is a Cross-Reactive Renal Target for Pathogenic Anti-DNA Antibodies The Journal of Immunology ·Bisram Deocharan, Xiaoping Qing, Juan Javier Lichauco, Chaim Putterman	2002	168

About Xiaoping Qing

Xiaoping Qing is a scholar working on Immunology, Nephrology, Rheumatology, Infectious Diseases and Otorhinolaryngology, having authored 23 papers that have together received 1.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (6 papers), Viral Infections and Outbreaks Research (6 papers), T-cell and B-cell Immunology (6 papers), Systemic Lupus Erythematosus Research (5 papers), Cervical Cancer and HPV Research (4 papers), Renal Diseases and Glomerulopathies (3 papers), Immunotherapy and Immune Responses (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Nephrology (199 citations), Rheumatology (390 citations), Immunology (540 citations), Immunology and Allergy (85 citations) and Oncology (217 citations). Xiaoping Qing has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Chaim Putterman, Jane E. Salmon, Juan Javier Lichauco, Bisram Deocharan, Patricia Redecha, Milena Pitashny, Tak W. Mak, Carl Blobel, Priya D. Issuree and Thorsten Maretzky. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Immunology, Journal of Clinical Investigation, European Journal of Immunology and Frontiers in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact